Advertisement
Screener

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Increase (Decrease) in Accounts Payable, Trade

2.8 / 5 stars · 68/120 Roast Me

MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable, Trade

MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) in Accounts Payable, Trade of -$17.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-07-30

  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$21.14M.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $3.58M.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was $4.94M.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $5.96M, a 83.88% decline year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for fiscal 2025 was $5.28M, a 66.07% decline from fiscal 2024.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for fiscal 2024 was $15.56M, a 269.55% increase from fiscal 2023.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was $4.21M, a 71.77% increase from fiscal 2022.
  • MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was $2.45M, a 87.96% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable, Trade 3 monthIncrease (Decrease) in Accounts Payable, Trade 3 month as first filedIncrease (Decrease) in Accounts Payable, Trade 6 monthIncrease (Decrease) in Accounts Payable, Trade 6 month as first filedIncrease (Decrease) in Accounts Payable, Trade 9 monthIncrease (Decrease) in Accounts Payable, Trade 9 month as first filedIncrease (Decrease) in Accounts Payable, Trade 12 monthIncrease (Decrease) in Accounts Payable, Trade 12 month as first filed
2026-06-30-$21.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$17.55M
10-Q · filed 2026-07-30
-$12.61M
derived: sum of 3 quarters · filed 2026-07-30
-$6.65M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$3.58M
10-Q · filed 2026-05-06
$8.53M
derived: sum of 2 quarters · filed 2026-05-06
$14.49M
derived: sum of 3 quarters · filed 2026-05-06
$10.41M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$4.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$10.90M
derived: sum of 2 quarters · filed 2026-02-19
$6.82M
derived: sum of 3 quarters · filed 2026-07-30
$5.28M
10-K · filed 2026-02-19
2025-09-30$5.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$1.88M
derived: sum of 2 quarters · filed 2026-07-30
$337.00K
10-Q · filed 2025-11-04
-$2.03M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$4.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$5.62M
10-Q · filed 2026-07-30
-$7.99M
derived: sum of 3 quarters · filed 2026-07-30
$28.98M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$1.54M
10-Q · filed 2026-05-06
-$3.91M
derived: sum of 2 quarters · filed 2026-05-06
$33.06M
derived: sum of 3 quarters · filed 2026-05-06
$25.53M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$2.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$34.60M
derived: sum of 2 quarters · filed 2026-02-19
$27.07M
derived: sum of 3 quarters · filed 2026-02-19
$15.56M
10-K · filed 2026-02-19
2024-09-30$36.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$29.44M
derived: sum of 2 quarters · filed 2025-11-04
$17.93M
10-Q · filed 2025-11-04
$29.42M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30-$7.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$19.05M
10-Q · filed 2025-08-05
-$7.55M
derived: sum of 3 quarters · filed 2026-02-19
-$8.54M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31-$11.51M
10-Q · filed 2025-05-01
-$14.00K
derived: sum of 2 quarters · filed 2026-02-19
-$1.01M
derived: sum of 3 quarters · filed 2026-02-19
$4.40M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$11.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$10.51M
derived: sum of 2 quarters · filed 2026-02-19
$15.91M
derived: sum of 3 quarters · filed 2026-02-19
$4.21M
10-K · filed 2026-02-19
2023-09-30-$992.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$4.41M
derived: sum of 2 quarters · filed 2024-10-31
-$7.29M
10-Q · filed 2024-10-31
-$2.02M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$5.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$6.30M
10-Q · filed 2024-08-07
-$1.03M
derived: sum of 3 quarters · filed 2025-02-26
$6.24M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31-$11.70M
10-Q · filed 2024-05-07
-$6.43M
derived: sum of 2 quarters · filed 2025-02-26
$834.00K
derived: sum of 3 quarters · filed 2025-02-26
-$10.65M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$5.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$12.54M
derived: sum of 2 quarters · filed 2025-02-26
$1.05M
derived: sum of 3 quarters · filed 2025-02-26
$2.45M
10-K · filed 2025-02-26
2022-09-30$7.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
-$4.22M
derived: sum of 2 quarters · filed 2023-11-06
-$2.82M
10-Q · filed 2023-11-06
$8.14M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$11.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$10.09M
10-Q · filed 2023-08-08
$876.00K
derived: sum of 3 quarters · filed 2024-02-28
$10.23M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$1.40M
10-Q · filed 2023-05-09
$12.36M
derived: sum of 2 quarters · filed 2024-02-28
$21.71M
derived: sum of 3 quarters · filed 2024-02-28
$18.38M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$10.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$20.31M
derived: sum of 2 quarters · filed 2024-02-28
$16.98M
derived: sum of 3 quarters · filed 2024-02-28
$20.36M
10-K · filed 2024-02-28
2021-09-30$9.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$6.02M
derived: sum of 2 quarters · filed 2022-11-03
$9.40M
10-Q · filed 2022-11-03
$4.14M
derived: sum of 4 quarters · filed 2023-03-03
2021-06-30-$3.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$50.00K
10-Q · filed 2022-08-04
-$5.21M
derived: sum of 3 quarters · filed 2023-03-03
-$3.94M
derived: sum of 4 quarters · filed 2023-03-03
2021-03-31$3.38M
10-Q · filed 2022-05-09
-$1.88M
derived: sum of 2 quarters · filed 2023-03-03
-$608.00K
derived: sum of 3 quarters · filed 2023-03-03
$3.28M
derived: sum of 4 quarters · filed 2023-03-03
2020-12-31-$5.26M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-03
-$3.99M
derived: sum of 2 quarters · filed 2023-03-03
-$98.00K
derived: sum of 3 quarters · filed 2023-03-03
-$161.00K
10-K/A · filed 2023-03-03
2020-09-30$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$5.16M
derived: sum of 2 quarters · filed 2021-11-04
$5.10M
10-Q · filed 2021-11-04
$5.50M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$3.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$3.83M
10-Q · filed 2021-08-05
$4.23M
derived: sum of 3 quarters · filed 2022-02-24
$4.56M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$63.00K
10-Q · filed 2021-05-06
$342.00K
derived: sum of 2 quarters · filed 2022-02-24
$669.00K
derived: sum of 3 quarters · filed 2022-02-24
-$3.26M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$405.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$732.00K
derived: sum of 2 quarters · filed 2022-02-24
-$3.20M
derived: sum of 3 quarters · filed 2022-02-24
-$1.31M
10-K · filed 2022-02-24
2019-09-30$327.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$3.60M
derived: sum of 2 quarters · filed 2020-11-05
-$1.71M
10-Q · filed 2020-11-05
-$258.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$3.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.04M
10-Q · filed 2020-08-06
-$585.00K
derived: sum of 3 quarters · filed 2021-02-25
-$142.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.89M
10-Q · filed 2020-05-07
$3.35M
derived: sum of 2 quarters · filed 2021-02-25
$3.79M
derived: sum of 3 quarters · filed 2021-02-25
$2.96M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.90M
derived: sum of 2 quarters · filed 2021-02-25
$1.07M
derived: sum of 3 quarters · filed 2021-02-25
$558.00K
10-K · filed 2021-02-25
2018-09-30$443.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$389.00K
derived: sum of 2 quarters · filed 2019-11-06
-$898.00K
10-Q · filed 2019-11-06
-$619.00K
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$832.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
-$1.34M
10-Q · filed 2019-08-07
-$1.06M
derived: sum of 3 quarters · filed 2020-02-26
-$947.00K
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$509.00K
10-Q · filed 2019-05-08
-$230.00K
derived: sum of 2 quarters · filed 2020-02-26
-$115.00K
derived: sum of 3 quarters · filed 2020-02-26
-$1.61M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31$279.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$394.00K
derived: sum of 2 quarters · filed 2020-02-26
-$1.10M
derived: sum of 3 quarters · filed 2020-02-26
$917.00K
10-K · filed 2020-02-26
2017-09-30$115.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$1.38M
derived: sum of 2 quarters · filed 2018-11-06
$638.00K
10-Q · filed 2018-11-06
$240.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$523.00K
10-Q · filed 2018-08-07
$125.00K
derived: sum of 3 quarters · filed 2019-02-27
-$134.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$2.02M
10-Q · filed 2018-05-08
$1.62M
derived: sum of 2 quarters · filed 2019-02-27
$1.36M
derived: sum of 3 quarters · filed 2019-02-27
$1.52M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$398.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$657.00K
derived: sum of 2 quarters · filed 2019-02-27
-$496.00K
derived: sum of 3 quarters · filed 2019-02-27
-$128.00K
10-K · filed 2019-02-27
-$128.06K
10-K · filed 2017-03-31
2016-09-30-$259.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$98.00K
derived: sum of 2 quarters · filed 2017-11-09
$270.00K
10-Q · filed 2017-11-09
$269.74K
10-Q · filed 2016-11-14
$27.52K
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$161.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$529.00K
10-Q · filed 2017-08-10
-$619.00K
10-Q · filed 2016-07-20
$286.52K
derived: sum of 3 quarters · filed 2017-08-10
$737.08K
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$368.00K
10-Q · filed 2017-05-11
-$555.00K
10-Q · filed 2016-05-10
$125.52K
derived: sum of 2 quarters · filed 2017-05-11
$576.08K
derived: sum of 3 quarters · filed 2017-05-11
-$142.92K
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31-$242.48K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-31
$208.08K
derived: sum of 2 quarters · filed 2017-03-31
-$510.92K
derived: sum of 3 quarters · filed 2017-03-31
$87.08K
10-K · filed 2017-03-31
-$1.84M
10-K · filed 2016-03-15
2015-09-30$450.56K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-03-31
-$268.44K
derived: sum of 2 quarters · filed 2017-03-31
$329.56K
10-Q/A · filed 2017-03-31
-$1.72M
10-Q · filed 2015-11-05
-$973.44K
derived: sum of 4 quarters · filed 2017-03-31
2015-06-30-$719.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20
-$121.00K
10-Q · filed 2016-07-20
-$1.42M
derived: sum of 3 quarters · filed 2016-07-20
-$2.21M
derived: sum of 4 quarters · filed 2016-07-20
2015-03-31$598.00K
10-Q · filed 2016-05-10
-$705.00K
derived: sum of 2 quarters · filed 2016-05-10
-$1.49M
derived: sum of 3 quarters · filed 2016-05-10
-$2.07M
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31-$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$2.09M
derived: sum of 2 quarters · filed 2016-03-15
-$2.67M
derived: sum of 3 quarters · filed 2016-03-15
-$3.45M
10-K · filed 2016-03-15
2014-09-30-$784.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$1.37M
derived: sum of 2 quarters · filed 2015-11-05
-$2.15M
10-Q · filed 2015-11-05
-$1.25M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30-$583.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$1.36M
10-Q · filed 2015-08-06
-$467.00K
derived: sum of 3 quarters · filed 2016-03-15
$5.00K
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$780.00K
10-Q · filed 2015-05-07
$116.00K
derived: sum of 2 quarters · filed 2016-03-15
$588.00K
derived: sum of 3 quarters · filed 2016-03-15
$90.00K
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$896.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$1.37M
derived: sum of 2 quarters · filed 2016-03-15
$870.00K
derived: sum of 3 quarters · filed 2016-03-15
$928.00K
10-K · filed 2016-03-15
2013-09-30$472.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
-$26.00K
derived: sum of 2 quarters · filed 2014-11-06
$32.00K
10-Q · filed 2014-11-06
$2.00M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30-$498.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
-$440.00K
10-Q · filed 2014-08-06
$1.53M
derived: sum of 3 quarters · filed 2015-03-12
$1.75M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$58.00K
10-Q · filed 2014-05-08
$2.03M
derived: sum of 2 quarters · filed 2015-03-12
$2.25M
derived: sum of 3 quarters · filed 2015-03-12
$2.68M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$1.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$2.19M
derived: sum of 2 quarters · filed 2015-03-12
$2.62M
derived: sum of 3 quarters · filed 2015-03-12
$2.19M
10-K · filed 2015-03-12
2012-09-30$222.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04
$650.00K
derived: sum of 2 quarters · filed 2013-11-04
$223.00K
10-Q · filed 2013-11-04
$768.00K
derived: sum of 4 quarters · filed 2014-03-11
2012-06-30$428.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
$1.00K
10-Q · filed 2013-08-01
$546.00K
derived: sum of 3 quarters · filed 2014-03-11
$1.47M
derived: sum of 4 quarters · filed 2014-03-11
2012-03-31-$427.00K
10-Q · filed 2013-04-30
$118.00K
derived: sum of 2 quarters · filed 2014-03-11
$1.04M
derived: sum of 3 quarters · filed 2014-03-11
$1.35M
derived: sum of 4 quarters · filed 2014-03-11
2011-12-31$545.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11
$1.47M
derived: sum of 2 quarters · filed 2014-03-11
$1.78M
derived: sum of 3 quarters · filed 2014-03-11
$1.54M
10-K · filed 2014-03-11
2011-09-30$923.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$1.23M
derived: sum of 2 quarters · filed 2012-11-06
$997.00K
10-Q · filed 2012-11-06
$529.00K
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30$308.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
$74.00K
10-Q · filed 2012-08-02
-$394.00K
derived: sum of 3 quarters · filed 2013-03-14
$719.00K
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31-$234.00K
10-Q · filed 2012-05-03
-$702.00K
derived: sum of 2 quarters · filed 2013-03-14
$411.00K
derived: sum of 3 quarters · filed 2013-03-14
2010-12-31-$468.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
$645.00K
derived: sum of 2 quarters · filed 2013-03-14
-$2.03M
10-K · filed 2013-03-14
2010-09-30$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03
-$1.56M
10-Q · filed 2011-11-03
2010-06-30-$2.68M
10-Q · filed 2011-08-04
2009-12-31$626.00K
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05